The coronavirus disease (COVID-19) has no approved treatment or vaccine as the world grapple with its wrath. The viral infection has so far infected 1.8 million and killed more than 114,000 people. Now, a team of scientists has shown that an experimental antiviral drug, remdesivir, has shown promise in treating patients with severe COVID-19.
In a small group of patients hospitalized with severe complications of COVID-19, a team of health experts has found that that remdesivir, a nucleotide analog that inhibits viral RNA polymerases, has shown in vitro activity against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19.
